<DOC>
	<DOCNO>NCT00989547</DOCNO>
	<brief_summary>Type 1 diabetes ( T1D ) still associate tremendous morbidity premature mortality . Patients require multiple daily insulin injection throughout life well close monitor diet blood sugar level prevent complication . Unfortunately , presently permanent cure diabetes . Whole pancreas islet cell transplantation available limited number patient necessitate potential lifelong immunosuppressive therapy . Autologous stem cell transplant use successfully ALL ( acute lymphoblastic leukemia ) , AML ( acute myeloblastic leukemia ) treatment variety cancer include breast cancer neuroblastoma , recently treatment autoimmune disorder multiple sclerosis ( MS ) , lupus-like disease , rheumatic disorder . Recently show bone marrow-derived stem cell transplant diabetic mouse lead reduced hyperglycemia within 7 day transplantation sustain sacrifice 35 day post-transplantation . The investigator ' goal transfuse autologous umbilical cord blood 23 child ( Germany 10 20 Controls ) T1D attempt regenerate pancreatic islet insulin produce beta cell improve blood glucose control . As secondary goal , investigator aim track migration transfuse cord blood stem study potential change metabolism/immune function lead islet regeneration .</brief_summary>
	<brief_title>Cord Blood Infusion Type 1 Diabetes Mellitus ( T1DM )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Must diagnosis T1D store umbilical cord blood ( 10 patient seek ) cord bank Vita 34 . TID diagnosis define clear history polydipsia , polyphagia , polyuria , weight loss consistent clinical diagnosis , diagnosis mot base solely upon presence autoantibody . Cord blood meet selection test criterion ( see ) . Normal screen value CBC , Renal function electrolyte ( BMP ) . Willing comply intensive diabetes management Not younger 1 year age Have complicate medical issue would interfere blood draw monitoring . Require chronic use steroid immunosuppressive agent condition . Cord Blood viability &lt; 50 % . Positive infectious disease marker mother blood cord time collection ( See detail ) . Any evidence illness plan infusion date ( i.e . fever &gt; 38.5 C , vomit , diarrhea , wheeze , crackle ) .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>